Further Evaluation Of The C3H 10T 1/2 Cell Transformation Assay For Use In Screening Chemicals For Carcinogenic Potential.
Public Domain
-
1984/01/01
-
Details
-
Personal Author:
-
Description:The C3H 10T 1/2 clone 8 cell transformation assay was evaluated for possible use in a battery short term assay for determining the carcinogenic potential of chemicals. The assay was originally developed for use with polycyclic aromatic hydrocarbons (PAHs). The assay was tested against 3-methylcholanthrene (56495) (MCA), 7,12- dimethylbenz(a)anthracene (57976) (DMBA), benzo(a)pyrene (50328) (BaP), dibenz(a,h)anthracene (53703) (DBA), the noncarcinogenic PAHs phenanthrene (85018) and anthracene (120127), and N-methyl-N'-nitro- N-nitrosoguanidine (70257) (MNNG). Positive responses were obtained with MCA, DMBA, and BaP. The response to DBA was marginal. MNNG, phenanthrene, and anthracene gave negative responses. The assay was used to test 20 coded carcinogens by two laboratories. Less than 50 percent of the compounds showed a clear transformation response in either laboratory. Forty five percent of the known carcinogens were identified as inducing either positive or suspect activity in one laboratory, whereas 85 percent were identified as either positive or suspect agents in the other laboratory. To broaden the responsiveness of the assay and to limit false negative results, the assay was modified by varying the target cell density, increasing the duration of treatment, delaying the treatment of plated target cells, amplifying the phenotypic transformation by delaying replating of treated target cells, or using exogenous metabolic supplements such as liver S9 mix. Eighteen compounds were evaluated by the C3H 10T 1/2 system after modification. The results were compared with the known in-vivo carcinogenicity of the compounds. Two results were inconclusive. Fourteen compounds, 88 percent, yielded results that agreed with the available in-vivo data. One false negative, pararosaniline (569619) was found and one agent, dimethylnitrosamine (62759) yielded suspect activity. The authors suggest that the modified C3H 10T 1/2 assay can be used as a reliable screening test to complement in-vitro cell assays. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Document Type:
-
Genre:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:215-261
-
NIOSHTIC Number:nn:00156965
-
Citation:NIOSH 1984:215-261
-
CAS Registry Number:3-Methylcholanthrene (CAS RN 56-49-5) ; 7,12-Dimethylbenz[a]anthracene (CAS RN 57-97-6) ; Anthracene (CAS RN 120-12-7) ; Benzo[a]pyrene (CAS RN 50-32-8) ; Dibenz[a,h]anthracene (CAS RN 53-70-3) ; N-Methyl-N′-nitro-N-nitrosoguanidine (CAS RN 70-25-7) ; N-Nitrosodimethylamine (CAS RN 62-75-9) ; Pararosaniline (CAS RN 569-61-9) ; Phenanthrene (CAS RN 85-01-8)
-
Federal Fiscal Year:1984
-
Peer Reviewed:False
-
Source Full Name:Proceedings of the Third NCI/EPA/NIOSH Collaborative Workshop: Progress on Joint Environmental and Occupational Cancer Studies
-
Collection(s):
-
Main Document Checksum:urn:sha-512:7dc847c09aedf140bc731323e8446b4703641ae07d6ad9e7b7238120dab30b8f7dcaa9b938d34d035f87873a0fe7fec262d5d13dcaf290925445e82b6de3b57d
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like